Для наиболее комфортного просмотра сайта, включите, пожалуйста, JavaScript в настройках браузера

About the company
Products
- Catalog
- Pharmacovigilance
For partners
For experts
- Events for professionals
Press center
Career
Contacts

Язык Russian version

Поиск

Home
Product Catalog
Rimantadine

Скачать фото упаковки

Rimantadine 50 mg №20_new png, 870,16 Кб

Rimantadine 50 mg №20 png, 490,16 Кб

Antiviral

ОТС

Rimantadine

ОТС

Active ingredient (INN): rimantadine
Composition (active ingredients): rimantadine hydrochloride - 50,0 mg
Фармакотерапевтическая группа: antiviral drug
Pharmacotherapeutic group: 50 mg tablets № 20
Сonditions of supply: over-the-counter

Indications

Indications

Prevention and early treatment of influenza A in adults and children older than 7 years

Contraindications

There are contraindications, consult with a specialist before use

Other products in this category

Valacyclovir Velpharm

Antiviral

Herpes virus inhibitor

Antiviral agent
INN Valacyclovir
Release form: film-coated tablets
On prescription

More details

Lamivudine Velpharm

Antiviral

VED

New packaging

Severe antiviral activity

Against human immunodeficiency virus (HIV)
INN Lamivudine
Release form: film-coated tablets
On prescription

More details

Acyclovir Velpharm

Antiviral

VED

New packaging

Severe antiviral activity

against herpes simplex virus, Varicella zoster virus, Epstein-Barr and Cytomegalovirus
INN Acyclovir
Release form: tablets
On prescription

More details

Contacts

Head Office, Moscow

proretail@velpharm.ru | +7 (495) 228 06 96

Production plant, Kurgan

center@velpharm.ru | +7 (3522) 48 60 00

Feedback Personal data processing policy
Consent to personal data processing Сводные ведомости СОУТ

Сводная ведомость СОУТ 2025 ООО Велфарм ОП Долгопрудный
Сводная ведомость рабочих мест по СОУТ 2024
Сводная ведомость рабочих мест ПАФС 2024
Сводные данные о результатах проведения специальной оценки условий труда Велтрэйд 2024
Сводная ведомость от 20.03.2023
Сводная ведомость от 09.03.2022
Сводная ведомость от 30.03.2021
Сводная ведомость от 28.07.2020
Сводная ведомость от 29.12.2018
Сводная ведомость от 29.12.2018_1
Сводная ведомость от 29.12.2018_2
Сводная ведомость от 20.03.2018
Сводные ведомости СОУТ

Перечни мероприятий по улучшению условий труда

Перечень мероприятий по СОУТ 2024
Перечень мероприятий ПАФС 2024
Перечень мероприятий по улучшению условий и охраны труда работников Велтрэйд 2024
Перечень мероприятий по СОУТ от 09.03.2022
Перечень мероприятий по СОУТ от 30.03.2021
Перечень мероприятий по СОУТ от 20.03.2018
Перечень мероприятий по СОУТ от 29.12.2018
Перечень мероприятий по СОУТ от 29.12.2018_1
Перечни мероприятий по улучшению условий труда

Website Design
Farm Studio №1 in RuNet

Form for
doctors / specialists

A doctor or other person reporting HP

Personal information

Name (required)

Position and place of work

Institutional Address

Phone

Email (required)

Date

Treatment:

Ambulatory

Stationary

Self-treatment

Report

First report date

Patient Information

Initials

№ ambulatory card or medical history

Gender

Male

Female

Age

Weight

Additional information

Pregnancy

Liver disorder

Impaired kidney

Allergy

What is allergic to

Presumptive Drug

International Nonproprietary Name (INN)

Trade Name (TN)

Manufacturer

Country

series number

Indication for appointment

Medicine route

Single/daily dose

Therapy start date

Discontinuation Date

Discovery date

HP dose

Other drugs taken over the past three months, including drugs taken by the patient on their own (by their own decision)

International Nonproprietary Name (INN)

Trade Name (TN)

Medicine route

Therapy start date

Discontinuation Date

Indication

Additional Information

HP Description

HP Start Date

Permission date

Drug withdrawal was accompanied by the disappearance of HP

There was a recurrence of HP after the re-appointment of drugs

Action taken

Without treatment

Cancel Suspected Drug

Suspected drug dose reduction

Cancel concomitant treatment

Drug therapy

Non-drug therapy (including surgery)

Other

Other measures

HP drug therapy if required

Exodus

Recovery without consequences

Hospitalization or its extension

State without dynamics

Birth of a child with a congenital anomaly

Death

Unknown

Other

Another outcome

Significant Additional Information

I agree to the processing of personal data (required)

Form for
patient/family

Dear customer!

If you have any complaints about an adverse reaction while taking our drug, leave the information here.

We ask you to describe in more detail the actions associated with the use of the drug.

Personal information

Your name (required)

Gender

Male

Female

Email (required)

Age

Medicine name

Medicine series

Side effects

Concomitant drugs

What washed down the drug

Measures taken to eliminate the side effect

The drug was prescribed

Doctor

Singly

I agree to the processing of personal data (required)

Send a resume

Personal information

Fullname (required)

Email (required)

Phone

Upload file

I agree to the processing of personal data (required)

Search input field

Information not found

Enter another request

Thanks! Form Submitted Successfully.

Thanks!

Your data has been sent successfully!

Используя сайт, вы предоставляете согласие на обработку ваших персональных данных с помощью сервисов веб-аналитики. Чтобы ознакомиться с нашими Положениями о конфиденциальности и об использовании файлов cookie, нажмите здесь.

Feedback

Personal information

Name (required)

Email (required)

Phone

Company

Message (required)

I agree to personal data processing (required)

I agree with the policy regarding the processing of personal data (required)

Rimantadine

Indications

Contraindications

Other products in this category

Valacyclovir Velpharm

Lamivudine Velpharm

Acyclovir Velpharm

Form for doctors / specialists

Form for patient/family

Send a resume

Feedback

Form for
doctors / specialists

Form for
patient/family